Cargando…

Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?

Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and the resulting coronavirus disease-19 (COVID-19) have led to a global pandemic associated with high fatality rates. COVID-19 primarily manifests in the respiratory system as an acute respiratory distress syndrome following viral entry t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sagris, Marios, Theofilis, Panagiotis, Antonopoulos, Alexios S., Oikonomou, Evangelos, Tsioufis, Kostas, Tousoulis, Dimitris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868779/ https://www.ncbi.nlm.nih.gov/pubmed/35203452 http://dx.doi.org/10.3390/biomedicines10020242

Ejemplares similares

The Anti-Inflammatory Effect of Novel Antidiabetic Agents
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
por: Theofilis, Panagiotis, et al.
Publicado: (2021)

Inflammatory Mechanisms Contributing to Endothelial Dysfunction
por: Theofilis, Panagiotis, et al.
Publicado: (2021)

Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Inflammation in Coronary Microvascular Dysfunction
por: Sagris, Marios, et al.
Publicado: (2021)

Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target
por: Sagris, Marios, et al.
Publicado: (2022)

Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives
por: Sagris, Marios, et al.
Publicado: (2021)

Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
por: Sagris, Marios, et al.
Publicado: (2021)

Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Pericoronary fat attenuation index—a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis
por: Sagris, Marios, et al.
Publicado: (2022)

Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Granulocyte Colony-Stimulating Factor Ameliorates Endothelial Activation and Thrombotic Diathesis Biomarkers in a Murine Model of Hind Limb Ischemia
por: Valatsou, Angeliki, et al.
Publicado: (2022)

The Role of Macrophages in Atherosclerosis: Pathophysiologic Mechanisms and Treatment Considerations
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment
por: Leopoulou, Marianna, et al.
Publicado: (2023)

Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes
por: Dimitroglou, Yannis, et al.
Publicado: (2023)

Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Pathophysiology of Acute Coronary Syndromes—Diagnostic and Treatment Considerations
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Imaging Subclinical Atherosclerosis: Where Do We Stand?
por: Papageorgiou, Nikolaos, et al.
Publicado: (2017)

The Role of Right Ventriculo–Arterial Coupling in Symptoms Presentation of Patients with Hypertrophic Cardiomyopathy
por: Angelopoulos, Andreas, et al.
Publicado: (2023)

The management of patent foramen ovale in divers: where do we stand?
por: Apostolos, Anastasios, et al.
Publicado: (2022)

Endothelial dysfunction in convalescent COVID-19 patients: Systematic review and meta-analysis
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches
por: Tsioufis, Panagiotis, et al.
Publicado: (2022)

Inflammatory Mediators of Endothelial Dysfunction
por: Dri, Eirini, et al.
Publicado: (2023)

Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives
por: Katsimichas, Themistoklis, et al.
Publicado: (2023)

Where Do We Stand?
Publicado: (1891)

The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
por: Agapidou, Alexandra, et al.
Publicado: (2016)

Selenium, Stroke, and Infection: A Threefold Relationship; Where Do We Stand and Where Do We Go?
por: Liampas, Andreas, et al.
Publicado: (2023)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study
por: Oikonomou, Evangelos, et al.
Publicado: (2022)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

The Effect of MicroRNA-126 Mimic Administration on Vascular Perfusion Recovery in an Animal Model of Hind Limb Ischemia
por: Theofilis, Panagiotis, et al.
Publicado: (2021)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Machine learning of native T1 mapping radiomics for classification of hypertrophic cardiomyopathy phenotypes
por: Antonopoulos, Alexios S., et al.
Publicado: (2021)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Pixel Detectors ... where do we stand?
por: Wermes, Norbert
Publicado: (2019)

Laser accelerators : where do we stand
por: Lawson, J D
Publicado: (1985)

Renormalization schemes: where do we stand?
por: Ward, B F L
Publicado: (1990)

Barrett's Esophagus: Where Do We Stand?
por: Al Madi, Majid A.
Publicado: (2009)

Maximizing neuroprotection: where do we stand?
por: Kuffler, Damien P
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_74i0bonn7c4qniieb2u4fv7p6l